GlassScriptPhysician profile
Moira Scaperotti
NPI 1760845564
$1,608.48
in general payments reported to CMS, 2019-2025
13 companies · $813 in 2025
The $813 reported for 2025 was less than what a typical Rheumatology provider received nationally (typical 2025 total: $894).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $112 · 2021: $262 · 2022: $421 · 2025: $813.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $799 · Education: $13.89.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $798.91 |
| Education | $13.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $330.05 | 2022-2025 | Evenity, Krystexxa, Uplizna |
| Novartis Pharmaceuticals Corporation | $313.24 | 2021-2025 | |
| Abbvie INC. | $264.51 | 2025 | |
| Janssen Biotech, INC. | $221.72 | 2021-2025 | Tremfya |
| Glaxosmithkline, LLC. | $126.35 | 2021-2025 | Benlysta |
| Regeneron Healthcare Solutions, INC. | $112.10 | 2019 | |
| Pfizer INC. | $81.50 | 2021 | |
| Aurinia Pharma U.S., INC. | $50.40 | 2025 | Lupkynis |
| Radius Health, INC. | $27.05 | 2025 | Tymlos |
| Si-Bone, INC. | $26.92 | 2021 | |
| Genzyme Corporation | $24.30 | 2025 | |
| Ani Pharmaceuticals, INC. | $17.52 | 2025 | Purified Cortrophin Gel |
| E.R. Squibb & Sons, L.L.C. | $12.82 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Moira Scaperotti listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.